Media & Events

Keep up-to-date on the latest media coverage and events for IceCure Medical.

Filter by:

News

COVID-19 Pandemic: Now is the Time to Embrace Healthcare Innovation by Tlalit Bussi

In this article, IceCure’s VP Business Development and Marketing, Tlalit Bussi Tel-Tzure’s discusses healthcare innovation in the time of COVID-19. The healthcare landscape has forever changed – are you ready? Read the full article here!

Read More >

News

ICECURE’S PROSENSE® TUMOR FREEZING PRODUCT APPROVED FOR MARKET IN SOUTH AFRICA

Following IceCure’s accelerating global expansion, the company has received regulatory approval for the treatment of benign and cancerous tumors in many indications including for the breast, lung, bone and kidney. Through their new exclusive partner,Tecmed Africa, IceCure’s technology will lead

Read More >

News

IceCure’s Global Expansion Accelerates; Tumor Freezing Product Now Approved for Market in India

New Indian regulatory approval received for its cryoablation technology to destroy tumors in extensive indications, including for breast, lung, bone and kidney cancer. Read more.

Read More >

IceCure Enters India

News

IceCure Enters German Cryoablation Oncology Market; Inks Exclusive Distribution Agreement with MTS Medical Technology

New German Territory Follows Accelerating Global Expansion with Orders in Singapore and Thailand This Month for Its Freezing Technology to Destroy Tumors. Read more.

Read More >

News

IceCure Continues Global Expansion to Freeze Tumors

New Territory in Singapore with Global Medical Leader, Terumo, Marks Successful Partnership Progress in Executing Milestone Distribution Agreement. Read more

Read More >